| 20-1232 |
IBSA Institut Biochimique, S. A., et al. v. Teva Pharmaceuticals USA, Inc. |
Federal Circuit |
2021-03-08 |
Denied |
Response Waived |
foreign-inventors foreign-language indefiniteness national-treatment patent patent-indefiniteness patent-priority patent-prosecution priority-date trips-agreement |
Whether, pursuant to the United States' obligations under the TRIPS Agreement, codified at 19 U.S.C. § 3511, a court construing the claims of a U.S. p… |